{"Signaling events mediated by PTP1B": ["YES1"], "Validated targets of C-MYC transcriptional repression": ["SMAD4"], "TGF-beta receptor signaling": ["SMAD4"], "Integrin-linked kinase signaling": ["ARHGEF7"], "Regulation of retinoblastoma protein": ["BRD2"], "Angiopoietin receptor Tie2-mediated signaling": ["GRB14"], "TCR signaling in na&#xef;ve CD4+ T cells": ["ORAI1"], "Thromboxane A2 receptor signaling": ["YES1"], "CXCR4-mediated signaling events": ["YES1"], "TCR signaling in na&#xef;ve CD8+ T cells": ["ORAI1"], "Beta1 integrin cell surface interactions": ["CSPG4"], "Downstream signaling in na&#xef;ve CD8+ T cells": ["PTPN7"], "LKB1 signaling events": ["SMAD4"], "Validated targets of C-MYC transcriptional activation": ["SMAD4"], "ErbB1 downstream signaling": ["BAIAP2"], "RhoA signaling pathway": ["PIP5K1B"], "Regulation of nuclear SMAD2/3 signaling": ["SMAD4"], "Validated nuclear estrogen receptor alpha network": ["SMAD4"], "Validated transcriptional targets of deltaNp63 isoforms": ["TOP2A"], "Class I PI3K signaling events": ["YES1"]}